Munich Reinsurance Co Stock Corp in Munich Acquires Shares of 5,569 HCA Healthcare, Inc. $HCA

Munich Reinsurance Co Stock Corp in Munich bought a new position in HCA Healthcare, Inc. (NYSE:HCA) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 5,569 shares of the company’s stock, valued at approximately $2,374,000.

Other institutional investors have also added to or reduced their stakes in the company. Angeles Wealth Management LLC boosted its position in shares of HCA Healthcare by 2.4% during the third quarter. Angeles Wealth Management LLC now owns 1,014 shares of the company’s stock valued at $432,000 after buying an additional 24 shares during the period. Evexia Wealth LLC lifted its stake in shares of HCA Healthcare by 16.7% during the 3rd quarter. Evexia Wealth LLC now owns 18,046 shares of the company’s stock worth $7,411,000 after acquiring an additional 2,589 shares during the last quarter. First Trust Advisors LP grew its position in HCA Healthcare by 46.5% in the 3rd quarter. First Trust Advisors LP now owns 127,552 shares of the company’s stock valued at $54,363,000 after acquiring an additional 40,476 shares during the last quarter. HUB Investment Partners LLC lifted its position in shares of HCA Healthcare by 42.1% during the third quarter. HUB Investment Partners LLC now owns 1,685 shares of the company’s stock worth $718,000 after purchasing an additional 499 shares during the last quarter. Finally, Modern Wealth Management LLC grew its holdings in shares of HCA Healthcare by 4.5% in the third quarter. Modern Wealth Management LLC now owns 610 shares of the company’s stock worth $260,000 after purchasing an additional 26 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on HCA shares. Oppenheimer upped their target price on shares of HCA Healthcare from $500.00 to $540.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 28th. UBS Group boosted their price target on HCA Healthcare from $598.00 to $635.00 and gave the company a “buy” rating in a report on Monday, February 23rd. Morgan Stanley lowered HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $425.00 target price for the company. in a research report on Monday, December 15th. Zacks Research lowered HCA Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Thursday, November 27th. Finally, Argus increased their target price on shares of HCA Healthcare from $530.00 to $560.00 and gave the stock a “buy” rating in a report on Friday, February 6th. Sixteen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $534.50.

HCA Healthcare Trading Down 0.2%

Shares of NYSE HCA opened at $533.63 on Friday. The stock has a market capitalization of $119.33 billion, a PE ratio of 18.80, a price-to-earnings-growth ratio of 1.64 and a beta of 1.34. HCA Healthcare, Inc. has a 12-month low of $310.18 and a 12-month high of $552.90. The stock’s fifty day simple moving average is $500.34 and its two-hundred day simple moving average is $465.40.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 earnings per share for the quarter, beating analysts’ consensus estimates of $7.37 by $0.64. The company had revenue of $19.51 billion for the quarter, compared to the consensus estimate of $19.67 billion. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The firm’s revenue for the quarter was up 6.7% compared to the same quarter last year. During the same quarter last year, the company earned $6.22 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th will be given a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, March 17th. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.72. This represents a $3.12 dividend on an annualized basis and a yield of 0.6%. HCA Healthcare’s dividend payout ratio is currently 10.99%.

Insider Activity

In other news, EVP Michael R. Mcalevey sold 1,694 shares of the company’s stock in a transaction on Wednesday, February 18th. The stock was sold at an average price of $533.37, for a total transaction of $903,528.78. Following the transaction, the executive vice president directly owned 8,853 shares of the company’s stock, valued at approximately $4,721,924.61. This represents a 16.06% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Christopher F. Wyatt sold 4,000 shares of the business’s stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $505.00, for a total value of $2,020,000.00. Following the transaction, the senior vice president owned 44,379 shares in the company, valued at approximately $22,411,395. This trade represents a 8.27% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 15,214 shares of company stock valued at $7,797,595 over the last three months. Company insiders own 1.30% of the company’s stock.

Key HCA Healthcare News

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Analyst sentiment and research upgrades: several outlets and analysts continue to rate HCA favorably — one consensus snapshot called the stock a “Moderate Buy,” reflecting continued analyst confidence that HCA can grow earnings and return capital to shareholders. Article Title
• Positive Sentiment: Long-term demographic bull case: MarketBeat argues HCA is a likely beneficiary of U.S. aging demographics, noting management’s strong guidance (FY2026 EPS and EBITDA ranges), expanded capex, a $10B repurchase authorization and a raised dividend — all supportive of long‑term growth and shareholder returns. Article Title
• Neutral Sentiment: Analyst estimate tweaks from Zacks: Zacks Research nudged near‑term EPS estimates slightly higher for Q2, Q3 and Q4 2026 and raised FY2026 to $29.63, which supports the earnings outlook, but it kept a “Hold” rating — a modest positive but not a strong endorsement. Article Title
• Neutral Sentiment: Zacks’ view is mixed farther out: while FY2026 estimates were lifted, Zacks trimmed its FY2028 EPS forecast modestly — a sign analysts see near‑term strength but some uncertainty on longer‑term margin expansion. Article Title
• Neutral Sentiment: Local/industry headlines are mixed and mostly non‑company specific: a local hospital (Manchester’s Catholic Medical Center) plans to end outpatient mental‑health services and a leadership hire at Methodist Healthcare were reported — signals about regional capacity and staffing but with limited direct impact on HCA’s large national footprint. Article Title Article Title
• Negative Sentiment: Near‑term policy and revenue risks remain prominent: recent company commentary and market writeups note revenue growth was slightly below expectations in the prior quarter and management flagged $600–$900M of potential EBITDA headwinds from insurance‑exchange changes plus state supplemental payment declines — factors that could cap near‑term upside despite strong EPS. Article Title

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.